Kerecis

Kerecis Omega3 Wound

Product Description

Kerecis Omega3 Wound is fish derived, naturally lyophilized acellular dermal matrix (ADM) wound treatment material.

Kerecis Omega3 Wound maintains and supports a healing environment for the management of wounds, where viable (red) tissue can be seen in the wound base.

The product has been used to treat wounds of the following etiologies:

  • Pressure ulcers
  • Venous ulcers
  • Chronic vascular ulcers
  • Diabetic ulcers
  • Traumatic ulcer
  • Recurring ulcer in a burn scar
  • Surgical wound (after failed heel surgery)
  • Necrotic wound (after injection, in a coagulopatic patient)
  • Salvation of split graft

Kerecis Omega3 Wound is supplied sterile in peel-open packages and is intended for one-time use.



Reference: www.kerecis.com
More information please contact us
Please notice the warning on the label and accompanying documents before use
*This device should not be used in patients with a known allergy or other sensitivity to fish material.

Manufacturer

  • Company: Kerecis Limited
  • Address: Eyrargata 2, 400 Isafjordur, Iceland
  • Tel: +354 562 2601
  • Email: info@kerecis.com
  • website: www.kerecis.com

Distributor

  • Company: Athenee Medical Co., Ltd.
  • Address: 470/17 Soi Pattanakarn12,Pattanakarn Road, Suanluang, Suanluang, BangkokThailand10250
  • Tel: 02-7199936-7
  • Email: customer@atheneemed.co.th
License No. ฆพ. 1051/2558